Beckman Research Institute of City of Hope

Total Awards: 
14
Award Value: 
$55,090,333
Institution type: 
Not for profit

Awards to the Institution

Award Value
Strategic Partnership III Track A: John Zaia A Phase I, Open-Label Study to Assess the Safety, Feasibility and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified Autologous CD34+ Hematopoietic Stem/Progenitor Cells with Escalating Doses of Busulfan in HIV-1 (R5) Infected Subjects with Suboptim $5,583,438
Creativity Awards: Paul Salvaterra Creativity Award Program in Stem Cell Biology for California High School Students $207,251
Early Translational III: Stephen Forman Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells $5,217,004
Research Training II: Michael Barish Research Training Program in Stem Cell Biology $2,500,143
Basic Biology III: Jiing-Kuan Yee Use of human iPS cells to study spinal muscular atrophy $1,268,868
New Faculty I: Tiziano Barberi Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy $131,840
Tools and Technologies I: Larry Couture Development of Suspension Adaptation, Scale-up cGMP Banking and Cell Characterization Technologies for hESC Lines $882,929
SEED Grant: Timothy O'Connor Sources of Genetic Instability in Human Embryonic Stem Cells. $327,311
Disease Team Research I: John Zaia ZIinc Finger Nuclease-Based Stem Cell Therapy for AIDS $14,573,835
Disease Team Research I: Karen Aboody Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials $18,015,429
Basic Biology IV: Yanhong Shi Modeling Alexander disease using patient-specific induced pluripotent stem cells $1,367,172
Early Translational II: David DiGiusto Development of RNA-based approaches to stem cell gene therapy for HIV $3,124,130
Disease Team Planning: Michael Barish Genetically-modified neural stem cells for treatment of high-grade glioma $55,000
Early Translational II: Yanhong Shi Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell $1,835,983
Total:
$55,090,333.00
Icon for xls export

© 2013 California Institute for Regenerative Medicine